Literature DB >> 215990

Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.

B L Devine, H A Carmichael, R I Russell, S N Joffe.   

Abstract

A patient is described who presented with the classical symptomatology and profound electrolyte disturbance of the Verner-Morrison syndrome due to a pancreatic apudoma secreting vasoactive intestinal polypeptide (VIP). Diagnosis was confirmed by plasma VIP as measured by a radio-immunoassay technique now available. It is suggested that the cyclical nature of the symptoms in this case was due to cyclical release of VIP from the tumour in response to an unknown stimulus. Perfusion studies confirmed the excess secretory state of water, sodium and chloride in the small intestine. Symptoms were completely abolished by surgery and the progress is being monitored by means of serial plasma VIP estimations to detect any early recurrence of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215990      PMCID: PMC2425268          DOI: 10.1136/pgmj.54.634.566

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia.

Authors:  J V VERNER; A B MORRISON
Journal:  Am J Med       Date:  1958-09       Impact factor: 4.965

2.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

Authors:  S I Said; G R Faloona
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

3.  Pancreatic cholera: benefical effects of treatment with streptozotocin.

Authors:  C R Kahn; A G Levy; J D Gardner; J V Miller; P Gorden; P S Schein
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

4.  Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.

Authors:  C J Schwartz; D V Kimberg; H E Sheerin; M Field; S I Said
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

5.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

6.  Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide.

Authors:  M Bodanszky; Y S Klausner; S I Said
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

7.  The effect of conjugated and unconjugated bile acids on water and electrolyte absorption in the human jejunum.

Authors:  R I Russell; J G Allan; V P Gerskowitch; K M Cochran
Journal:  Clin Sci Mol Med       Date:  1973-09

8.  Intestinal secretion: stimulation by peptides.

Authors:  G O Barbezat; M I Grossman
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

9.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.